Cargando…

Medullary Thyroid Cancer: Updates and Challenges

A personalized approach to the management of medullary thyroid cancer (MTC) presents several challenges; however, in the past decade significant progress has been made in both diagnostic and treatment modalities. Germline rearranged in transfection (RET) testing in multiple endocrine neoplasia 2 and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gild, Matti L, Clifton-Bligh, Roderick J, Wirth, Lori J, Robinson, Bruce G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656709/ https://www.ncbi.nlm.nih.gov/pubmed/37204852 http://dx.doi.org/10.1210/endrev/bnad013

Ejemplares similares

Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma
por: Kesby, Nicholas, et al.
Publicado: (2023)

Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge
por: Gild, Matti L, et al.
Publicado: (2022)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Selpercatinib Treatment of RET-Mutated Thyroid Cancers Is Associated With Gastrointestinal Adverse Effects
por: Tsang, Venessa, et al.
Publicado: (2022)

Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update
por: Worrall, Benjamin J, et al.
Publicado: (2023)

Development of a novel clinical support tool for active surveillance of low risk papillary thyroid cancer
por: White, Eleanor, et al.
Publicado: (2023)

A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative Necrosis
por: Fuchs, Talia L., et al.
Publicado: (2020)

Thyroid Hormone Abuse Among Elite Athletes
por: Handelsman, David J, et al.
Publicado: (2023)

Destabilizing RET in targeted treatment of thyroid cancers
por: Gild, M L, et al.
Publicado: (2015)

Metastatic papillary thyroid cancer to cerebellum with incidental medullary microcarcinoma
por: Wang, Mawson, et al.
Publicado: (2022)

Infiltrative lymphocytic hypophysitis successfully treated with rituximab and mycophenolate mofetil
por: Lin, Mike, et al.
Publicado: (2020)

RF11 | PSAT370 I-PET Score: Combining Whole Body Iodine Scan and 18 Fluorodeoxyglucose Positron Emission Topography to Predict Progression in Thyroid Cancer
por: Wijewardene, Ayanthi, et al.
Publicado: (2022)

Medullary Thyroid Carcinoma: An Update on Imaging
por: Kushchayev, Sergiy V., et al.
Publicado: (2019)

Update on Targeted Therapy in Medullary Thyroid Cancer
por: Okafor, Christian, et al.
Publicado: (2021)

Molecular Markers Guiding Thyroid Cancer Management
por: Nylén, Carolina, et al.
Publicado: (2020)

15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
por: Benn, Diana E, et al.
Publicado: (2015)

Medullary carcinoma of the thyroid: an update
por: Alevizaki, Maria
Publicado: (2013)

Medullary Thyroid Cancer – Feature Review and Update on Systemic Treatment
por: Dabelić, Nina, et al.
Publicado: (2020)

Recent Updates on the Management of Medullary Thyroid Carcinoma
por: Kim, Bo Hyun, et al.
Publicado: (2016)

Malignant struma ovarii with a robust response to radioactive iodine
por: Gild, M L, et al.
Publicado: (2020)

ACTH-secreting medullary thyroid cancer: a case series
por: Wijewardene, Ayanthi A, et al.
Publicado: (2017)

LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer
por: Wirth, Lori J, et al.
Publicado: (2022)

Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
por: Kaliszewski, Krzysztof, et al.
Publicado: (2022)

Diagnosis of medullary thyroid cancer
por: Marchisotta, Stefania, et al.
Publicado: (2009)

Treatment of advanced medullary thyroid cancer
por: Smit, Johannes
Publicado: (2013)

An Introduction to Managing Medullary Thyroid Cancer
por: de Groot, Jan Willem, et al.
Publicado: (2006)

Noncoding RNA blockade of autophagy is therapeutic in medullary thyroid cancer
por: Gundara, Justin S, et al.
Publicado: (2015)

Proteomics of thyroid tumours provides new insights into their molecular composition and changes associated with malignancy
por: Martínez-Aguilar, Juan, et al.
Publicado: (2016)

Targeted Treatment of Differentiated and Medullary Thyroid Cancer
por: Bales, Shannon R., et al.
Publicado: (2011)

Genetic and Epigenetic of Medullary Thyroid Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2018)

Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid Carcinoma
por: Raue, Friedhelm, et al.
Publicado: (2018)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
por: Degrauwe, Nils, et al.
Publicado: (2012)

Role of vandetanib in the management of medullary thyroid cancer
por: Brassard, Maryse, et al.
Publicado: (2012)

Advanced medullary thyroid cancer: pathophysiology and management
por: Ferreira, Carla Vaz, et al.
Publicado: (2013)

How I treat medullary thyroid cancer
por: Kiesewetter, B., et al.
Publicado: (2021)

The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
por: Clifton-Bligh, Roderick J.
Publicado: (2023)

A multiplexed, targeted mass spectrometry assay of the S100 protein family uncovers the isoform-specific expression in thyroid tumours
por: Martínez-Aguilar, Juan, et al.
Publicado: (2015)

Immune Related Adverse Events of the Thyroid – A Narrative Review
por: Muir, Christopher A., et al.
Publicado: (2022)

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer
por: Ricci, Claudia, et al.
Publicado: (2023)

Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment
por: Fugazzola, L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ti3gh5agg1o7oarjtb0gil47g6